Takeda Pharmaceutical EBITDA 2012-2025 | TAK

Takeda Pharmaceutical annual and quarterly EBITDA history from 2012 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Takeda Pharmaceutical EBITDA for the quarter ending September 30, 2025 was $2.527B, a 196.73% increase year-over-year.
Takeda Pharmaceutical EBITDA for the twelve months ending September 30, 2025 was $7.988B, a 4.81% increase year-over-year.
Takeda Pharmaceutical 2025 annual EBITDA was $7.286B, a 12.09% increase from 2024.
Takeda Pharmaceutical 2024 annual EBITDA was $6.5B, a 23.94% decline from 2023.
Takeda Pharmaceutical 2023 annual EBITDA was $8.546B, a 8.02% decline from 2022.

Takeda Pharmaceutical Annual EBITDA (Millions of US $)
2025	$7,286
2024	$6,500
2023	$8,546
2022	$9,292
2021	$28,741
2020	$6,293
2019	$4,297
2018	$3,815
2017	$3,521
2016	$2,724
2015	$1,198
2014	$3,550
2013	$3,916
2012	$4,991
2011	$15,749

Takeda Pharmaceutical Quarterly EBITDA (Millions of US $)
2025-06-30	$2,527
2024-06-30	$2,295
2024-03-31	$1,216
2023-12-31	$1,950
2023-09-30	$852
2023-06-30	$2,483
2023-03-31	$2,021
2022-12-31	$2,267
2022-09-30	$1,881
2022-06-30	$2,378
2022-03-31	$1,326
2021-12-31	$2,236
2021-09-30	$2,166
2021-06-30	$3,563
2021-03-31	$21,322
2020-12-31	$2,772
2020-09-30	$1,774
2020-06-30	$2,873
2020-03-31	$1,306
2019-12-31	$1,341
2019-09-30	$1,952
2019-06-30	$1,694
2018-12-31	$1,001
2018-06-30	$910
2017-06-30	$1,755
2016-06-30	$1,422
2015-06-30	$406
2015-03-31	$3,673
2014-12-31	$-10,919
2014-09-30	$4,076
2014-06-30	$612
2014-03-31	$3,982
2013-12-31	$4,528
2013-09-30	$4,222
2013-06-30	$509
2013-03-31	$3,722
2012-12-31	$4,959
2012-09-30	$4,936
2012-06-30	$892
2012-03-31	$4,816
2011-12-31	$5,484
2011-09-30	$4,454
2011-03-31	$4,113

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$50.721B	$30.087B
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide acetate for the treatment of prostate cancer and endometriosis, pioglitazone hydrocholoride for the treatment of diabetes, and candesartan cilexetil for the treatment of hypertension. The Company promotes enhancing R&D pipeline, while concentrating its management resources to the four core therapeutic areas: lifestyle-related diseases, oncology and urological diseases, central nervous system disease and gastroenterological diseases. It operates in two segments- Ethical drug business and Consumer healthcare business. Consumer healthcare business provides Alinamin (vitamin B1 derivative preparations, etc.), Benza (cold remedies). Takeda Pharmaceutical Company Limited is headquartered in Osaka, Japan.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$87.081B	33.08
Zoetis (ZTS)	United States	$54.822B	19.62
Daiichi Sankyo, - (DSNKY)	Japan	$37.925B	18.89
BeOne Medicines - (ONC)	Switzerland	$37.155B	196.98
Sandoz Group AG (SDZNY)	Switzerland	$34.654B	0.00
United Therapeutics (UTHR)	United States	$20.325B	17.89
Merck (MKKGY)	Germany	$19.522B	12.04
Shionogi (SGIOY)	Japan	$16.214B	14.89
Neurocrine Biosciences (NBIX)	United States	$13.697B	32.86
Summit Therapeutics (SMMT)	United States	$13.395B	0.00
IPSEN (IPSEY)	France	$13.337B	0.00
Ionis Pharmaceuticals (IONS)	United States	$13.248B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$11.311B	0.00
Orion OYJ (ORINY)	Finland	$10.204B	29.15
Eisai (ESAIY)		$8.236B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$6.967B	21.19
Grifols, S.A (GRFS)	Spain	$6.264B	0.00
Stevanato Group S.p.A (STVN)	Italy	$5.802B	32.47
Crinetics Pharmaceuticals (CRNX)	United States	$5.214B	0.00
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.547B	0.00
Corcept Therapeutics (CORT)	United States	$4.344B	46.93
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.269B	20.27
Indivior (INDV)	United States	$4.193B	17.11
NewAmsterdam Pharma (NAMS)	Netherlands	$3.947B	0.00
Centessa Pharmaceuticals (CNTA)	United Kingdom	$3.313B	0.00
Hypermarcas (HYPMY)	Brazil	$3.192B	21.91
Catalyst Pharmaceuticals (CPRX)	United States	$3.005B	9.59
Dyne Therapeutics (DYN)	United States	$2.582B	0.00
Ocular Therapeutix (OCUL)	United States	$2.369B	0.00
Soleno Therapeutics (SLNO)	United States	$2.350B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.103B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$1.959B	23.22
Ardelyx (ARDX)	United States	$1.927B	0.00
Guardian Pharmacy Services (GRDN)	United States	$1.924B	37.06
Amylyx Pharmaceuticals (AMLX)	United States	$1.782B	0.00
Oruka Therapeutics (ORKA)	United States	$1.720B	0.00
Harrow (HROW)	United States	$1.679B	103.00
Enliven Therapeutics (ELVN)	United States	$1.604B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.489B	7.37
BioCryst Pharmaceuticals (BCRX)	United States	$1.422B	84.38
Relay Therapeutics (RLAY)	United States	$1.317B	0.00
Savara (SVRA)	United States	$1.314B	0.00
Evotec AG (EVO)	Germany	$1.275B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.263B	0.00
Aktis Oncology (AKTS)	United States	$1.135B	0.00
Theravance Biopharma (TBPH)	United States	$1.051B	44.13
ARS Pharmaceuticals (SPRY)	United States	$1.045B	0.00
Cronos Group (CRON)	Canada	$1.023B	0.00
Xencor (XNCR)	United States	$0.936B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.877B	20.73
KalVista Pharmaceuticals (KALV)	United States	$0.836B	0.00
Esperion Therapeutics (ESPR)	United States	$0.758B	0.00
Nektar Therapeutics (NKTR)	United States	$0.743B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.688B	6.15
Bioventus (BVS)	United States	$0.675B	13.81
ProKidney (PROK)	United States	$0.656B	0.00
Altimmune (ALT)	United States	$0.561B	0.00
Lexeo Therapeutics (LXEO)	United States	$0.561B	0.00
Lyell Immunopharma (LYEL)	United States	$0.549B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.511B	0.00
Organogenesis (ORGO)	United States	$0.508B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.494B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.491B	0.00
Siga Technologies (SIGA)	United States	$0.482B	6.60
4D Molecular Therapeutics (FDMT)	United States	$0.462B	0.00
Nature's Sunshine Products (NATR)	United States	$0.429B	25.56
USANA Health Sciences (USNA)	United States	$0.412B	11.48
Aquestive Therapeutics (AQST)	United States	$0.397B	0.00
Cybin (HELP)	Canada	$0.385B	0.00
Akebia Therapeutics (AKBA)	United States	$0.382B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.314B	0.00
Protara Therapeutics (TARA)	United States	$0.305B	0.00
Avalo Therapeutics (AVTX)	United States	$0.301B	0.00
OmniAb (OABI)	United States	$0.298B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.294B	0.00
Relmada Therapeutics (RLMD)	United States	$0.290B	0.00
Larimar Therapeutics (LRMR)	United States	$0.286B	0.00
Fractyl Health (GUTS)	United States	$0.284B	0.00
Profound Medical (PROF)	Canada	$0.281B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.275B	0.00
Heron Therapeutics (HRTX)	United States	$0.266B	0.00
Journey Medical (DERM)	United States	$0.251B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.249B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.231B	0.00
Galectin Therapeutics (GALT)	United States	$0.228B	0.00
MediWound (MDWD)	Israel	$0.225B	0.00
Century Therapeutics (IPSC)	United States	$0.202B	0.00
AleAnna (ANNA)	United States	$0.187B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
Surrozen (SRZN)	United States	$0.171B	0.00
Minerva Neurosciences (NERV)	United States	$0.169B	0.00
Context Therapeutics (CNTX)	United States	$0.164B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.161B	0.00
VAXART, INC (VXRT)	United States	$0.159B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.156B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.153B	0.00
Prelude Therapeutics (PRLD)	United States	$0.139B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.135B	0.00
Avita Medical (RCEL)	United States	$0.126B	0.00
Incannex Healthcare (IXHL)	Australia	$0.124B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.124B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.122B	0.00
Cassava Sciences (SAVA)	United States	$0.112B	0.00
Vivani Medical (VANI)	United States	$0.107B	0.00
Pyxis Oncology (PYXS)	United States	$0.106B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.104B	0.00
Korro Bio (KRRO)	United States	$0.099B	0.00
Champions Oncology (CSBR)	United States	$0.096B	40.76
Gain Therapeutics (GANX)	United States	$0.080B	0.00
PolyPid (PYPD)	Israel	$0.076B	0.00
Assertio Holdings (ASRT)	United States	$0.075B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.069B	0.00
Dominari Holdings (DOMH)	United States	$0.068B	0.00
Metagenomi Therapeutics (MGX)	United States	$0.066B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.064B	0.00
Arch Biopartners (ACHFF)	Canada	$0.062B	0.00
Rafael Holdings (RFL)	United States	$0.062B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.061B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.060B	50.50
Lipocine (LPCN)	United States	$0.058B	0.00
ElectroCore (ECOR)	United States	$0.056B	0.00
Nutriband (NTRB)	United States	$0.055B	0.00
Lite Strategy (LITS)	United States	$0.049B	0.00
Talphera (TLPH)	United States	$0.047B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.046B	0.00
Plus Therapeutics (PSTV)	United States	$0.040B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.039B	0.00
Wellgistics Health (WGRX)	United States	$0.036B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.034B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.032B	0.00
SCYNEXIS (SCYX)	United States	$0.032B	0.00
TherapeuticsMD (TXMD)	United States	$0.030B	0.00
Natural Alternatives (NAII)	United States	$0.027B	0.00
Klotho Neurosciences (KLTO)	United States	$0.025B	0.00
Liminatus Pharma (LIMN)	United States	$0.021B	0.00
Scienture Holdings (SCNX)	United States	$0.021B	0.00
Traws Pharma (TRAW)	United States	$0.020B	0.03
Inotiv (NOTV)	United States	$0.020B	0.00
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Cosmos Health (COSM)	United States	$0.019B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.019B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.018B	0.00
Vivos Therapeutics (VVOS)	United States	$0.017B	0.00
Vyome Holdings (HIND)	United States	$0.016B	0.00
Tempest Therapeutics (TPST)	United States	$0.015B	0.00
Mannatech (MTEX)	United States	$0.014B	0.00
BioLineRx (BLRX)	Israel	$0.013B	0.00
CASI Pharmaceuticals (CASI)	China	$0.012B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.012B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.011B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.010B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.010B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.010B	0.00
BioVie (BIVI)	United States	$0.009B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.009B	0.00
Nuvilex (PMCB)	United States	$0.009B	0.00
Ainos (AIMD)	United States	$0.009B	0.00
Mangoceuticals (MGRX)	United States	$0.009B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.009B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.008B	0.00
Biomerica (BMRA)	United States	$0.008B	0.00
Heatwurx (PCSA)	United States	$0.007B	0.00
Redhill Biopharma (RDHL)	Israel	$0.007B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.007B	0.00
Indaptus Therapeutics (INDP)	United States	$0.006B	0.00
Xenetic Biosciences (XBIO)	United States	$0.006B	0.00
Aptorum Group (APM)	United Kingdom	$0.006B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.006B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
Clearmind Medicine (CMND)	Canada	$0.004B	0.00
Lyra Therapeutics (LYRA)	United States	$0.004B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.004B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.004B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.003B	0.00
Jaguar Animal Health (JAGX)	United States	$0.003B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
PainReform (PRFX)	Israel	$0.002B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.001B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00